Abstract: We report a 72-year-old man who was admitted to our department with multiple nodules of hepatocellular carcinoma (HCC) in a cirrhotic liver because of HCV infection. Unlike most of the nodules, one in segment 2 (S2) showed hypoattenuation on computed tomography (CT) during hepatic arteriography (CT A), and hyperattenuation on CT during arterial portography (CT AP). Fine needle aspiration biopsy of the nodule established the .diagnosis of hepatic adenomatous hyperplasia.
INTRODUCTION
CT during hepatic arteriography (CT A) and CT during arterial portography (CT AP) are used to detect small nodular hepatic lesions, such as early small hepatocellular carcinoma (HCC) or advanced HCO-S,9.1l. [12] [13] [14] [15] [16] [17] [18] [19] [20] . Typical HCC nodules show hyperattenuation on CT A, and hypoattenuation on CT AP, indicating hypervascularity and decrease or absence of portal bl ood flow into the nodules 2 ,6,9, 1l ,20 ) .
H owever, we encountered a nodule that showed an untypical pattern, hypo attenuation on CT A, and hyperattenuati on on CT AP. We report this rare case, and attempt to determine the reason why the phenomenon occurred.
CA SE RE PORT
A 72 -year old man was referred to Department of Internal Medicine II, Fukushima Medical University Hospital, in May 2002, because HCC nodules were detected by abdomina l enha nced CT at another hospital near his house. He had been di agnosed with liver cirrhosis with a HCC nodule at 64 years of age. HCV infection was also detected. He underwent posteri or segmentectomy of the liver for HCC at Department of Surger y I, Fukushima Medical University H ospital, at 65, and was foll owed up a t another hospital. In July 2002, two months after the referral, he was admitted to Department of Internal Medicine II for additi onal investigati on and treatment. On physical examina tion, the liver and spleen were palpable, indicating hepatosplenomegaly. Laboratory findings were as foll ows. He had liver dysfunction, AST was 106 (l0-30) IU / I, and AL T was 123 (6 -29) IU / 1. Total bilirubin was 1.7 (0 .4-l. 2) mg/ dl. Gamma GT P was 156 (7-55) IU/ 1. Pla telet count was 9. nodule did not show tumor stain, but the S8 nodul es did ( Fig. 1 ). CT AP and CT A were performed in the IVR-CT room, using a multislice CT scan system (Aquilion™, TSX -lOlA, TOSHIBA). For CT AP, about 30 ml of iohexol (Omnipaque; 300 mg/ ml , Daiichi , Tokyo) was used, and was inj ected into the superior mesenteri c a rtery (SMA) from a 5Fr angiographic catheter tip. CT AP scan was taken 25 seconds after contrast medium injection at the rate of 3 ml/ sec. CT A was performed 6 seconds after inj ection of contrast medium at lml / sec through a 4F angiographic catheter placed in the common or proper hepatic arter y. The S8 nodu les showed hypoattenuati on on CTAP, and hyperattenuation on CT A compared with the surrounding cirrhotic parenchyma ( Fig. 2A, B) . The S2 nodule, however, showed hyperattenuation on CT AP, and hypoattenuation on CT A (Fig. 3A, B) . A specimen of the S2 nodule obtained by a fine needle aspiration biopsy (FNAB) was pathologicall y examined. The specimen showed a slightly increased cell density with an elevated nuclear/cytoplasmic r atio, vari ous sizes of hepatocytes, but no structur al variant (Fig. 3) . So the diagnosis of hepatic adenomatous hyperplasia (AH) was established.
The advanced HCC nodules in S8 were treated with transcatheter arterial emboli zation, and the S2 nodule by percutaneous ethanol inj ection just after FNAB was performed. He was discharged in September 2002, and is being followed up as of April 2005. The normal liver parenchyma is mainl y perfused by porta l bl ood flow. HCC, however, is perfused by hepatic arterial flow (hypervascularity), and portal blood flo w is decreased or absent in ie,6,9,11 -19) Therefore, HCC nodules demonstrate hyperattenuation on CT A, and hypoattenuation or absence of enhancement on CTAP. On the other hand, because AH nodul es are usua ll y simil ar in vascular construction to the surrounding hepatic parenchyma, they show isodensity on CT A, and iso -or slightly low density on CT AP. These differences in CT images of HCC and AH nodules are nowadays considered to be correlated with the prognosis (i .e., grade of malignancy) of hepatic nodules, and a lso with the pathologic conditions 2 ,9, 19). In Department of Interna l Medicine II , Fukushima Med ical Uni versity H ospita l, CT AP was performed during the period from April 2002 to December 2004 in 156 consecutive patients with 268 nodules. Of these, onl y this one showed hyperattenuation on CTAP, and a lso this was the onl y hi stologica lly confirmed AH nodul e of a ll subj ected to angio-CT. There are ver y few such cases in the English literature l , 3 .4 ,5) liVhy the S2 nodule shows hyperattenuati on on CT AP is not clear. There are 5 possibilities; one of them is that the surrounding cirrhotic parenchyma is demonstrated as relatively low in density because the portal blood Row in the segment or lobule decreases a long with the development of liver damage, as reported by Takayasu el al. I).
In our case, the pa renchyma surrounding the S2 nodule showed slightl y lower enhancement than the right lobe of the liver, and the left lobe was enhanced unevenly. Another possibility is actually increased portal blood flow into the nodule caused by the perfusing vessels. Takayasu et at. report nodule-in-nodule HCC enhanced on both CT AP and CT A. However, their tumor was not enhanced uniformly, probably because there was biased vascular distribution. In our case, however, large portal veins were improbable, because angio-CT showed neither large portal veins nor arterial hypervascular appearance, and we were unable to observe large blood vessels in the FNAB specimen, even though it was too small. A third possibility is the existence of abdominal arterial variation. Actually, Koops et at. report that anatomical arterial variations (common hepatic artery or right hepatic artery or accessory artery forking off from SMA) were found in 98 of 604 patients (16.2%) subjected to angiographic studies 20 ) . Nodules perfused by such arteries can be enhanced on CT AP phase. In our case, no arterial variation was observed in the celiac artery or SMA, and so this hypothesis does not hold.
A fourth possibility is concerned with technical problems when CT AP is performed. Some of the arteries that branch off from the SMA can contribute to the overflow of contrast medium into hepatic nodules through abnormal circulation to the portal blood system (i.e., from abnormal pancreatic arcade)!). Another problem is that the prolonged enhancement of a HCC nodule taken from a different vessel line may be recognized as hyperattenuation on CT AP. However, we routinely perform CT AP first in the process of angiographic examination. Contrast medium is injected from the SMA trunk using a 5Fr catheter tip with low pressure (3 ml/sec.) to avoid regurgitation. Actually, we observed no abnormal arteries or regurgitation from the SMA, and there was no trouble during the test.
The last possibility is that CT AP findings represent only one period of vascular transformation from AH to advanced HCC. Histopathological studies have described multi-step carcinogenesis 6 • 7 • 10 ) . In the course of carcinogenesis, vascular transformation is thought to occur as follows: (1) portal veins gradually decrease in number, (2) original normal arteries decrease in number, (3) abnormal arteries increase in number and portal blood flow further decreases, and finally (4) HCC with rich abnormal arterial blood flow and no portal blood flow develops. Thus, there should be a period when the portal blood flow is higher in density than the arterial flow or surrounding cirrhotic parenchyma. This view can also explain why a S2 nodule shows hypoattenuation on CT A.
In conclusion, because hepatic nodules that show hyperattenuation on CT AP can demonstrate various grades of malignancy, some other tests (e.g., MRI, color Doppler US) are necessary to rule out malignancy potential. Histological examination should be performed by all means. If a nodule grows very slowly, its grade of malignancy may be low. Further investigation is needed to explain this phenomenon.
